BACKGROUND: Thromboelastography measures the dynamics of coagulation. There are limited data about thromboelastography in acute ischemic stroke other than a single study from 1974 suggesting that acute ischemic stroke patients are hypercoagulable. There have been no studies of thromboelastography in the thrombolytic era despite its potential usefulness as a measure of clot lysis. This study was designed to provide initial thromboelastography data in stroke patients before and after tissue plasminogen activator therapy and to provide the necessary preliminary data for further study of thromboelastography's ability to identify clot subtype and predict response to tissue plasminogen activator therapy. METHODS: All acute ischemic stroke patients presenting between 11/2009 and 2/2011 eligible for tissue plasminogen activator therapy were screened and 56 enrolled. Blood was drawn before (52 patients) and 10 mins after tissue plasminogen activator bolus (30 patients). Demographics, vitals, labs, 24 h National Institutes of Health Stroke Scale, and computed tomography scan results were collected. Patients were compared with normal controls. RESULTS: Acute ischemic stroke patients had shorter R (4.8 ± 1.5 vs. 6.0 ± 1.7 min, P = 0.0004), greater α Angle (65.0 ± 7.6 vs. 61.5 ± 5.9°, P = 0.01), and shorter K (1.7 ± 0.7 vs. 2.1 ± 0.7 min, P = 0.002) indicating faster clotting. Additionally, a subset formed clots with stronger platelet-fibrin matrices. Treatment with tissue plasminogen activator resulted in reduction in all indices of clot strength (LY30 = 0 (0-0.4) vs. 94.4 (15.2-95.3) P < 0.0001); however, there was considerable variability in response. CONCLUSIONS: Thromboelastography demonstrates that many acute ischemic stroke patients are hypercoaguable. Thromboelastography values reflect variable clot subtype and response to tissue plasminogen activator. Further study based on these data will determine if thromboelastography is useful for measuring the dynamic aspects of clot formation and monitoring lytic therapy.
BACKGROUND: Thromboelastography measures the dynamics of coagulation. There are limited data about thromboelastography in acute ischemic stroke other than a single study from 1974 suggesting that acute ischemic strokepatients are hypercoagulable. There have been no studies of thromboelastography in the thrombolytic era despite its potential usefulness as a measure of clot lysis. This study was designed to provide initial thromboelastography data in strokepatients before and after tissue plasminogen activator therapy and to provide the necessary preliminary data for further study of thromboelastography's ability to identify clot subtype and predict response to tissue plasminogen activator therapy. METHODS: All acute ischemic strokepatients presenting between 11/2009 and 2/2011 eligible for tissue plasminogen activator therapy were screened and 56 enrolled. Blood was drawn before (52 patients) and 10 mins after tissue plasminogen activator bolus (30 patients). Demographics, vitals, labs, 24 h National Institutes of Health Stroke Scale, and computed tomography scan results were collected. Patients were compared with normal controls. RESULTS: Acute ischemic strokepatients had shorter R (4.8 ± 1.5 vs. 6.0 ± 1.7 min, P = 0.0004), greater α Angle (65.0 ± 7.6 vs. 61.5 ± 5.9°, P = 0.01), and shorter K (1.7 ± 0.7 vs. 2.1 ± 0.7 min, P = 0.002) indicating faster clotting. Additionally, a subset formed clots with stronger platelet-fibrin matrices. Treatment with tissue plasminogen activator resulted in reduction in all indices of clot strength (LY30 = 0 (0-0.4) vs. 94.4 (15.2-95.3) P < 0.0001); however, there was considerable variability in response. CONCLUSIONS: Thromboelastography demonstrates that many acute ischemic strokepatients are hypercoaguable. Thromboelastography values reflect variable clot subtype and response to tissue plasminogen activator. Further study based on these data will determine if thromboelastography is useful for measuring the dynamic aspects of clot formation and monitoring lytic therapy.
Authors: Wilfried W H Roeloffzen; Hanneke C Kluin-Nelemans; Andre B Mulder; Nic J G M Veeger; Lotte Bosman; Joost Th M de Wolf Journal: Anesth Analg Date: 2010-04-01 Impact factor: 5.108
Authors: Rajat S Barua; Fridolin Sy; Sundararajan Srikanth; Grace Huang; Usman Javed; Cyrus Buhari; Dennis Margosan; John A Ambrose Journal: Arterioscler Thromb Vasc Biol Date: 2009-10-08 Impact factor: 8.311
Authors: David S Liebeskind; Nerses Sanossian; William H Yong; Sidney Starkman; Michael P Tsang; Antonio L Moya; David D Zheng; Anna M Abolian; Doojin Kim; Latisha K Ali; Samir H Shah; Amytis Towfighi; Bruce Ovbiagele; Chelsea S Kidwell; Satoshi Tateshima; Reza Jahan; Gary R Duckwiler; Fernando Viñuela; Noriko Salamon; J Pablo Villablanca; Harry V Vinters; Victor J Marder; Jeffrey L Saver Journal: Stroke Date: 2011-03-10 Impact factor: 7.914
Authors: S Scarpelini; S G Rhind; B Nascimento; H Tien; P N Shek; H T Peng; H Huang; R Pinto; V Speers; M Reis; S B Rizoli Journal: Braz J Med Biol Res Date: 2009-10-30 Impact factor: 2.590
Authors: I K Jang; H K Gold; A A Ziskind; J T Fallon; R E Holt; R C Leinbach; J W May; D Collen Journal: Circulation Date: 1989-04 Impact factor: 29.690
Authors: M Saqqur; G Tsivgoulis; C A Molina; A M Demchuk; M Siddiqui; J Alvarez-Sabín; K Uchino; S Calleja; A V Alexandrov Journal: Neurology Date: 2008-08-27 Impact factor: 9.910
Authors: Mark M McDonald; Jeremy Wetzel; Stuart Fraser; Andrea Elliott; Ritvij Bowry; Jorge F Kawano-Castillo; Chunyan Cai; Navdeep Sangha; Jessica Messier; Amanda Hassler; Joancy Archeval-Lao; Stephanie A Parker; Mohammad H Rahbar; Evan G Pivalizza; Tiffany R Chang; James C Grotta Journal: J Thromb Thrombolysis Date: 2016-04 Impact factor: 2.300
Authors: Santosh B Murthy; Mary Cushman; Dylan Bobrow; Hooman Kamel; Alexander E Merkler; Mitchell S V Elkind; Lisa M DeAngelis; Babak B Navi Journal: J Clin Neurosci Date: 2018-08-23 Impact factor: 1.961
Authors: Ritvij Bowry; Stuart Fraser; Joancy M Archeval-Lao; Stephanie A Parker; Chunyan Cai; Mohammad H Rahbar; James C Grotta Journal: Stroke Date: 2014-01-14 Impact factor: 7.914
Authors: Mark M McDonald; Joancy M Archeval-Lao; Chunyan Cai; Hui Peng; Navdeep Sangha; Stephanie A Parker; Jeremy Wetzel; Stephen A Riney; Matt F Cherches; Greer J Guthrie; Tiffany C Roper; Jorge F Kawano-Castillo; Renga Pandurengan; Mohammad H Rahbar; James C Grotta Journal: Stroke Date: 2013-12-26 Impact factor: 7.914
Authors: Tareq S Almaghrabi; Mark M McDonald; Chunyan Cai; Mohammed H Rahbar; H Alex Choi; Kiwon Lee; Neeraj S Naval; James C Grotta; Tiffany R Chang Journal: Int J Cerebrovasc Dis Stroke Date: 2019-01-18
Authors: Adam Wiśniewski; Aleksandra Karczmarska-Wódzka; Joanna Sikora; Przemysław Sobczak; Adam Lemanowicz; Karolina Filipska; Robert Ślusarz Journal: Diagnostics (Basel) Date: 2021-04-15
Authors: Mitchell J George; Karthik Prabhakara; Naama E Toledano-Furman; Yao-Wei Wang; Brijesh S Gill; Charles E Wade; Scott D Olson; Charles S Cox Journal: Stem Cells Transl Med Date: 2018-08-01 Impact factor: 6.940